Future Cor -Non-Synthetic and Regenerative Devices for Cardiovascular System

The future devices and improvements to the CorMatrix ECM® technology are allowing the company to design better non-synthetic and regenerative devices for the cardiovascular system from heart valves and grafts to heart failure platforms. By maintaining the functional proteins within a normal structural matrix, the patient’s host stem cells are recruited in a proliferative, non-inflammatory and angiogenic environment forming new blood vessels. This may lead to the formation and remodeling of the patient’s normal tissue rather than scar or calcification.